Big Pharma

RFK Jr.: It’s time for real vaccine accountability—and HHS just took the first step

The Wall Street Journal, Approved, Commentary, National / / , , , , , , , , ,

Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning.

Some would try to explain this away by blaming misinformation or antiscience attitudes. To do so, however, ignores a history of conflicts of interest, persecution of dissidents, a lack of curiosity, and skewed science that has plagued the vaccine regulatory apparatus for decades.
That is why, under my direction, the U.S. Department of Health and Human Services is putting the restoration of public trust above any pro- or antivaccine agenda. The public must know that unbiased science guides the recommendations from our health agencies. This will ensure the American people receive the safest vaccines possible.

RFK Jr.: It’s time for real vaccine accountability—and HHS just took the first step Read More »

Joondeph: Make prescription drugs affordable again

American Thinker, Approved, Commentary, National / / , , , , , ,

Last week, President Donald Trump grabbed his Sharpie and signed an executive order to tackle the sky-high prescription drug prices in the U.S. The plan? A “Most Favored Nation” (MFN) pricing model that aligns U.S. drug costs with those of other countries. 

Sound familiar? Trump tried this during his first term, but the courts rejected it, and Biden hit the ‘undo’ button.

Here’s the lowdown on why Trump is back at it, what’s at stake, and whether this bold move will stick.

Joondeph: Make prescription drugs affordable again Read More »

Profit or patients? The 340B fight that could close Colorado hospitals

Top Stories, Approved, Rocky Mountain Voice, State / / , , , ,

If Senate Bill 25-071 fails, Julie Lonborg says her neighbor could end up driving from Lone Tree to Thornton just to pick up a single prescription. That’s not some theoretical what-if. It’s a glimpse into what hospital leaders say is already unfolding in Colorado, especially for patients in rural communities who depend on access to affordable medication through the federal 340B drug discount program.

Profit or patients? The 340B fight that could close Colorado hospitals Read More »

Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars

National, Approved, Breitbart / / , ,

During Robert F. Kennedy Jr.’s confirmation hearing on Wednesday, Senate Democrats criticized the healthcare nominee for chasing money and influence, while they have received millions of dollars from the healthcare industry.

Democrat critics of Robert F. Kennedy Jr. on the big pharma, healthcare dole for millions of dollars Read More »

Pharma giant seeks to join lawsuit against FDA over weight loss drugs 

National, Approved, THE HILL / / , , ,

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some pharmacies have practiced in mass-marketing copies of its highly popular GLP-1 medications.

Pharma giant seeks to join lawsuit against FDA over weight loss drugs  Read More »

Harris, Biden talk big on ‘Big Pharma’, but have accepted combined $11M in campaign donations since 1990

Approved, National, The Daily Signal / / , ,

President Joe Biden and Vice President Kamala Harris slammed Big Pharma for “inflating the price of lifesaving medications” in a speech Thursday in Largo, Maryland. But Biden and Harris’ congressional campaigns received $9 million and $2 million, respectively, from 1990-2024.

Harris, Biden talk big on ‘Big Pharma’, but have accepted combined $11M in campaign donations since 1990 Read More »